Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 981 across all filing types
Latest filing 2026-03-30 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
(1) CHANGE OF COMPANY SECRETARY, AUTHORISED REPRESENTATIVE AND PROCESS AGENT; (2) PROPOSED INCREASE IN REGISTERED CAPITAL; AND (3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Share Issue/Capital Change Classification · 1% confidence The announcement is a Hong Kong Exchange corporate announcement covering (1) resignation and appointment of the company secretary/authorised representative, (2) a proposed increase in registered capital through new share issues, and (3) amendments to the articles of association to reflect the increased capital. While it includes a management change, the primary substance is the proposed capital increase and share issuance. Under our taxonomy, this falls under Share Issue/Capital Change (SHA).
2026-03-30 English
FINAL DIVIDEND IN CASH FOR THE YEAR ENDED DECEMBER 31, 2025
Notice of Dividend Amount Classification · 1% confidence The document is a Hong Kong Stock Exchange announcement titled “FINAL DIVIDEND IN CASH FOR THE YEAR ENDED DECEMBER 31, 2025” and provides details on dividend type, amount per share, record date, payment date, and related tax information. This matches the ‘Notice of Dividend Amount’ category.
2026-03-30 English
NOTICE OF BOARD MEETING
Report Publication Announcement Classification · 1% confidence The document is a short announcement (1438 characters) titled 'NOTICE OF BOARD MEETING'. It informs shareholders that a board meeting will be held to consider and approve annual results and dividend recommendations. It does not contain the actual financial results or the report itself, but rather announces the upcoming publication/meeting date. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2026-03-16 English
ANNOUNCEMENT MADE PURSUANT TO RULE 13.10 OF THE LISTING RULES
Regulatory Filings Classification · 1% confidence The document is a formal announcement issued by Pharmaron Beijing Co., Ltd. in response to a request from the Stock Exchange of Hong Kong regarding recent press articles. It clarifies the company's position on a manufacturing collaboration and confirms there is no undisclosed inside information. As it is a general regulatory announcement regarding market rumors and compliance with Listing Rules, it does not fit into specific categories like financial reports or M&A, making 'RNS' (Regulatory Filings) the most appropriate classification.
2026-03-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026
Regulatory Filings Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and treasury shares. As it is a recurring regulatory filing mandated by the Exchange Listing Rules and does not fit into specific categories like earnings releases or annual reports, it is classified as a Regulatory Filing (RNS).
2026-03-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' filed with the Hong Kong Stock Exchange. This specific regulatory form tracks movements in securities, including changes in authorized/registered share capital and issued shares. According to the filing definitions, documents detailing share issues, capital changes, or movements in securities are classified as 'Share Issue/Capital Change' (SHA).
2026-02-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.